Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Latest filing published 24 Apr 2026 for Arrowhead Pharmaceuticals, INC., €642k. Read the official filing
Filing timeline
BuySaleJames C. Hamilton
Insider track record
Disclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
James C. Hamilton: trading record in brief
James C. Hamilton, listed as senior executive, appears in our data through filings on Arrowhead Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 1 January 2022 and 23 April 2026, the trades on record add up to 19 filings.
No open-market purchase appears, only 16 sales worth €4.7M. Outside the open market, there are 3 share grants. 2026 to date brings no purchases and 3 sales.
The latest filing, published on 24 April 2026, reports an open-market sale of €642k in Arrowhead Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James C. Hamilton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
10,000 shares@ US$75.000.0059% mcap15.6% of flowCommon StockSEC:0001830755-26-000007:0
10,000 shares@ US$64.1911.6% of flowCommon StockSEC:0001830755-26-000006:0
75,000 shares0Common StockSEC:0001830755-26-000004:0
4,625 shares@ US$61.240.0022% mcap5.9% of flowCommon StockSEC:0001830755-26-000002:0
20,000 shares@ US$35.000.0055% mcap14.5% of flowCommon StockSEC:0001830755-25-000011:0
15,000 shares@ US$30.006.5% of flowCommon StockSEC:0001830755-25-000009:0
15,000 shares@ US$25.007.7% of flowCommon StockSEC:0001830755-25-000007:0
611 shares@ US$20.000.3% of flowCommon StockSEC:0001830755-25-000005:0
21,758 shares@ US$19.687.0% of flowCommon StockSEC:0001628280-25-000807:1
10,971 shares@ US$20.113.6% of flowCommon StockSEC:0001628280-25-000807:2
100,000 shares0Common StockSEC:0001628280-25-000807:0
6,000 shares@ US$28.032.6% of flowCommon StockSEC:0001628280-24-014735:0
4,238 shares@ US$36.472.4% of flowCommon StockSEC:0001628280-24-001576:0
3,500 shares@ US$31.811.7% of flowCommon StockSEC:0001628280-24-000748:0
3,000 shares@ US$35.531.7% of flowCommon StockSEC:0001628280-23-024351:0
7,230 shares@ US$37.404.3% of flowCommon StockSEC:0001209191-23-002479:0
1,194 shares@ US$37.460.7% of flowCommon StockSEC:0001209191-23-002110:0
9,955 shares@ US$64.890.0053% mcap13.9% of flowCommon StockSEC:0001209191-22-002284:0
55,000 shares0Common StockSEC:0001209191-22-001313:0
19 of 19 declarations
